Top Vaccines companies in South Korea by EBIT Margin

This ranking features the top 19 Vaccines companies in South Korea ranked by EBIT Margin, averaging a EBIT Margin of -197.30%, for February 04, 2025.
#
Name
EBIT Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
31.79%
Dec. 31, 2023 USD 119.86 -2.20%

South Korea

2
8.81%
Dec. 31, 2023 USD 89.76 -4.42%

South Korea

3
7.83%
Dec. 31, 2023 USD 77.77 -3.69%

South Korea

4
6.84%
Dec. 31, 2023 USD 11.62 -0.90%

South Korea

5
5.94%
Dec. 31, 2023 USD 65.38 -0.04%

South Korea

6
2.36%
Dec. 31, 2023 USD 32.21 -3.61%

South Korea

7
2.08%
Dec. 31, 2023 USD 88.80 -5.65%

South Korea

8
0.43%
Dec. 31, 2023 USD 15.77 -2.26%

South Korea

9
-1.06%
Dec. 31, 2023 USD 9.61 -3.70%

South Korea

10
-3.00%
Dec. 31, 2023 USD 240.05 -5.25%

South Korea

11
-18.81%
Dec. 31, 2023 USD 8.83 4.03%

South Korea

12
-80.74%
Dec. 31, 2023 USD 10.77 -3.15%

South Korea

13
-84.99%
Dec. 31, 2023 USD 3.75 -3.31%

South Korea

14
-190.22%
Dec. 31, 2023 USD 1.42 -2.25%

South Korea

15
-237.16%
Dec. 31, 2023 USD 4.40 -2.27%

South Korea

16
-469.55%
Dec. 31, 2023 USD 1.65 -4.10%

South Korea

17
-749.28%
Dec. 31, 2023 USD 1.23 -3.88%

South Korea

18
-942.80%
Dec. 31, 2023 USD 1.61 -1.19%

South Korea

19
-1,037.12%
Dec. 31, 2023 USD 3.04 -3.81%

South Korea

Frequently Asked Questions
  • Which Vaccines company in South Korea has the highest EBIT Margin ?

    The Vaccines company in South Korea with the highest EBIT Margin is Celltrion, Inc. (KSE: 068270.KS) at 31.79%.

  • Which Vaccines company in South Korea has the lowest EBIT Margin ?

    The Vaccines company in South Korea with the lowest EBIT Margin is Genexine, Inc. (KOSDAQ: 095700.KQ) at -1,037.12%.

SV Wall Street